MARIA DOMINGUEZ: Open Payments
NPI 1891738449 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 24 payments from 11 companies in 2025. Trend: 2023 $1,344 · 2024 $531 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 6 | $113 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| Corium, LLC | 3 | $66 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
Products named: Qelbree, CAPLYTA, TRINTELLIX, Azstarys, Jornay PM, FANAPT, REXULTI, UZEDY.
Industry payments across TX — which companies pay providers there.
